期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^(18)F-FDG PET显像在恶性淋巴瘤中的应用 被引量：2

The applications of ^(18)F-FDG PET in malignant lymphoma
下载PDF
导出
摘要 18 F- FDG(1 8F-氟代脱氧葡萄糖 ) PET显像作为一种功能显像技术 ,能反映肿瘤组织中的生化变化和代谢状态 ,对淋巴瘤的准确分期、恶性程度评价、治疗疗效评价、治疗后复发的诊断以及预后估计等方面均具有重要作用。 As a medlod of fundional imaging, 18 F FDG PET provides a measure of the biochemical varieties as well as the metabolic status of the tissues, which condbute to the accmate staging, assessment of malignancy, curative effect and prognosis of lymphoma.
作者 张立颖
机构地区 上海第二医科大学附属瑞金医院核医学科
出处 《国外医学（放射医学核医学分册）》 2001年第1期10-12,共3页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
关键词 恶性淋巴瘤 ^18F-氟代脱氧葡萄糖 正电子发射断层显像 PET lymphoma 18 F auorodeoxyglucose positron emission tomography
分类号 R817.4 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献16

  • 1Moog F, Bangerter M, Diederichs CG, et al. Extranodal malignant lymphoma: detection with 18F-FDG PET versus CT[J]. Radiology, 1998, 206(2): 475-481.
  • 2Thill R, Neuerburg J, Fabry U, et al. Comparison of findings with 18-F-FDG PET and CT in pretherapeutic staging of malignant lymphoma [J]. Nukearmedizin,1997, 36(7) :234-239.
  • 3Hoh CK, Glaspy J, Rosen P, et al. Whole-body 18FFDG PET imaging for staging of Hodgkin's disease and lymphoma[J]. JNucl Med, 1997, 38(3):343-348.
  • 4Moog F, Kotzerke J, Reske SN. 18F-FDG PET call replace bone scintigraphy in primary stagiag of malignant lymphoma [J]. J Nucl Med, 1999,40 (9): 1407-1413.
  • 5Carr R, Barrington SF, Madan B. et al. Detection of lymphoma in bone marrow by whole-body positron e()mission tomoraphy [J]. Blood, 1998, 91 (9): 3340-3346.
  • 6Moog F, Bangerter M, Kotzerke J, et al. 18-F-fluorodeoxyglucose-positron emission tomograpby as a new approach to detect lymphomatous bone marrow[J]. J Clin Oncol, 1998,16(2): 603-609.
  • 7Lapela M, Leskiinen S, Minn HR, et al. Hlcreasedglucose metabolism in mlffeated non- Hodgkin's lym-phoma: a study with positon emission tomography andfluorine-18- auorodeoxyglucose [J]. Blood, 1995, 86(9) : 3522-3527.
  • 8Jerusalem G, Begnin Y, Fassotte MF, et al. Persis-tent tumor 18F-FDG uptake after a few cycles of poly-chemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma[J]. Haematologica, 2000, 85(6) : 613-618.
  • 9Romer W, Hallauske AR, Ziegler S, et al. Positron e-mission tomography in non-Hodgkin's lymphoma: as-sessment of chemodlerapy with fluorodeoxyglucose[J]. Blood, 1998, 91(12):4464-4471.
  • 10Calleuos GP. Residual mass in lymphoma may not beresidual disease[J]. J Clin Oncol, 1988,6(6) :931.

同被引文献27

  • 1余党凡,左传涛,戴嘉中,董孟杰,赵军,林祥通,管一晖.FDG-PET/CT在鼻咽癌放疗后随访中的初步应用研究[J].癌症,2004,23(z1):1538-1541. 被引量：7
  • 2朱晓霞,陈永清,陈龙华.PET/CT图像融合对骨转移瘤放射治疗肿瘤区勾画的影响[J].第一军医大学学报,2004,24(6):700-702. 被引量：7
  • 3胡永成,马宏庆.全国骨转移瘤治疗专题座谈会会议纪要[J].中华骨科杂志,2003,23(6):323-325. 被引量：19
  • 4Nehmeh SA, Erdi YE, Ling CC, et al. Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer.Med Phys, 2002, 29(3): 366-371.
  • 5Li ng CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys, 2000, 47(3): 551-560.
  • 6MacManus MP, Hicks BJ, Ball DL, et aL F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer, 2001, 92(4):886-895.
  • 7Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, et al. The impact of (18)F-fluoro-2-dexoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Racliother Oncol,2000, 55(3): 317-324.
  • 8Bradley JD, Perez CA, Dehdashti F, et al. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. J Nucl Med, 2004, 45(suppl 1): S96-S101.
  • 9Erdi YE, Bosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol, 2002, 62(1): 51-60.
  • 10Schmidt S, Nestle U, Walter K, et al. Optimization of radioth-erapy planning for non-small cell lung cancer(NSCLC) using ^18FDG-PET.Nuklearmedizin, 2002, 41(5): 217-220.

引证文献2

国外医学（放射医学核医学分册）
2001年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部